Skip to search formSkip to main contentSkip to account menu

BRL-26921

Known as: BRL 26921, BRL26921 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
We report the results of two consecutive studies using intravenous bolus injections of streptokinase (SK) or acylated plasminogen… 
1986
1986
BRL 26921 is a new acylated streptokinase-plasminogen complex which may have a more specific local thrombolytic effect than… 
1985
1985
The main goal of therapeutic thrombolysis in acute myocardial infarction is early reperfusion of acutely obstructed coronary… 
Highly Cited
1985
Highly Cited
1985
BRL 26921 is a protected plasminogen-streptokinase complex with selective affinity for thrombus. When given intravenously within… 
1984
1984
BRL 26921 is the p- anisoyl derivative of the primary streptokinase-human plasminogen complex in which the acyl group is…